FMP
AMEX
0.92 USD
0.1 (10.87%)
Mr. Michael A. Martino
Healthcare
Biotechnology
https://www.ampiopharma.com
AMEX
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged...
0001411906
US03209T3077
03209T109
373 Inverness Parkway
720 437 6500
US
5
Mar 31, 2010
0001411906
AMEX
Biotechnology
Healthcare
03209T109
US03209T3077
US
0.92
1.99
178.09k
765.46k
-
0.7-8.2
15.97
-
-
-
-
-0.08
-
https://www.ampiopharma.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.